In-depth insights into the antidiabetic activity of Dracaena trifasciata (Prain) Mabb. fractions and subfractions: In vitro and computational studies; [Análisis en profundidad de la actividad antidiabética de fracciones y subfracciones de Dracaena trifasciata (Prain) Mabb.: Estudios in vitro y computacionales]
Context: Dracaena trifasciata Prain has shown potential in pharmaceutical research, particularly for its antidiabetic properties. Investigating its effects on α-glucosidase enzyme inhibition can provide insights into its role as an antidiabetic agent. Aims: To evaluate the antidiabetic activity of t...
Published in: | Journal of Pharmacy and Pharmacognosy Research |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
2025
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-86000282478&doi=10.56499%2fjppres24.2193_13.s1.13&partnerID=40&md5=9e743031b59111df8a093c4782cdd2b1 |
id |
Kasmawati H.; Ruslin R.; Arfan A.; Sida N.A.; Wibowo A.; Hanafiah M.A.K.M.; Yahya M.F.M. |
---|---|
spelling |
Kasmawati H.; Ruslin R.; Arfan A.; Sida N.A.; Wibowo A.; Hanafiah M.A.K.M.; Yahya M.F.M. 2-s2.0-86000282478 In-depth insights into the antidiabetic activity of Dracaena trifasciata (Prain) Mabb. fractions and subfractions: In vitro and computational studies; [Análisis en profundidad de la actividad antidiabética de fracciones y subfracciones de Dracaena trifasciata (Prain) Mabb.: Estudios in vitro y computacionales] 2025 Journal of Pharmacy and Pharmacognosy Research 13 10.56499/jppres24.2193_13.s1.13 https://www.scopus.com/inward/record.uri?eid=2-s2.0-86000282478&doi=10.56499%2fjppres24.2193_13.s1.13&partnerID=40&md5=9e743031b59111df8a093c4782cdd2b1 Context: Dracaena trifasciata Prain has shown potential in pharmaceutical research, particularly for its antidiabetic properties. Investigating its effects on α-glucosidase enzyme inhibition can provide insights into its role as an antidiabetic agent. Aims: To evaluate the antidiabetic activity of the ethyl acetate fraction and subfractions from D. trifasciata against α-glucosidase through in vitro assay and analyze molecular interactions, absorption, distribution, metabolism, and excretion (ADME), toxicity, and stability through in silico studies. Methods: An α-glucosidase enzyme assay was performed using the ethyl acetate fraction (FE), subfraction C (SC), and subfraction E (SE) at concentrations of 100, 200, 300, 400, and 500 µg/mL. Acarbose was used as the control. Computational docking, drug-likeness, ADME and toxicity analysis, molecular dynamics, and Molecular Mechanics, General Born Surface Area (MM/GBSA) energy analysis were conducted on methyl pyrophaeophorbide A and (2S)-3',4'-methylenedioxy-5,7-dimethoxyflavone from SE against α-glucosidase. Results: At 500 µg/mL, the inhibition percentages for the FE, SC, SE, and acarbose (1 µg/mL) were 70.11%, 69.89%, 75.17%, and 72.20%, respectively. IC50 values were 170.82 µg/mL (FE), 183.47 µg/mL (SC), 74.89 µg/mL (SE), and 0.29 µg/mL (acarbose). Molecular docking showed (2S)-3',4'-methylenedioxy-5,7-dimethoxyflavone interacting with α-glucosidase via hydrogen bonds with Arg552 and hydrophobic interactions with Asp232, Trp329, Asp469, Asp568, and Phe601. Although the analysis results indicate a safer ADME profile and lower toxicity for methyl pyropheophorbide A compared to (2S)-3',4'-methylenedioxy-5,7-dimethoxyflavone. The (2S)-3',4'-methylenedioxy-5,7-dimethoxyflavone also demonstrated good stability and favorable binding energy (-33.86 kJ/mol) compared to acarbose. © 2025 Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA). All rights reserved. Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) 7194250 English Article |
author |
2-s2.0-86000282478 |
spellingShingle |
2-s2.0-86000282478 In-depth insights into the antidiabetic activity of Dracaena trifasciata (Prain) Mabb. fractions and subfractions: In vitro and computational studies; [Análisis en profundidad de la actividad antidiabética de fracciones y subfracciones de Dracaena trifasciata (Prain) Mabb.: Estudios in vitro y computacionales] |
author_facet |
2-s2.0-86000282478 |
author_sort |
2-s2.0-86000282478 |
title |
In-depth insights into the antidiabetic activity of Dracaena trifasciata (Prain) Mabb. fractions and subfractions: In vitro and computational studies; [Análisis en profundidad de la actividad antidiabética de fracciones y subfracciones de Dracaena trifasciata (Prain) Mabb.: Estudios in vitro y computacionales] |
title_short |
In-depth insights into the antidiabetic activity of Dracaena trifasciata (Prain) Mabb. fractions and subfractions: In vitro and computational studies; [Análisis en profundidad de la actividad antidiabética de fracciones y subfracciones de Dracaena trifasciata (Prain) Mabb.: Estudios in vitro y computacionales] |
title_full |
In-depth insights into the antidiabetic activity of Dracaena trifasciata (Prain) Mabb. fractions and subfractions: In vitro and computational studies; [Análisis en profundidad de la actividad antidiabética de fracciones y subfracciones de Dracaena trifasciata (Prain) Mabb.: Estudios in vitro y computacionales] |
title_fullStr |
In-depth insights into the antidiabetic activity of Dracaena trifasciata (Prain) Mabb. fractions and subfractions: In vitro and computational studies; [Análisis en profundidad de la actividad antidiabética de fracciones y subfracciones de Dracaena trifasciata (Prain) Mabb.: Estudios in vitro y computacionales] |
title_full_unstemmed |
In-depth insights into the antidiabetic activity of Dracaena trifasciata (Prain) Mabb. fractions and subfractions: In vitro and computational studies; [Análisis en profundidad de la actividad antidiabética de fracciones y subfracciones de Dracaena trifasciata (Prain) Mabb.: Estudios in vitro y computacionales] |
title_sort |
In-depth insights into the antidiabetic activity of Dracaena trifasciata (Prain) Mabb. fractions and subfractions: In vitro and computational studies; [Análisis en profundidad de la actividad antidiabética de fracciones y subfracciones de Dracaena trifasciata (Prain) Mabb.: Estudios in vitro y computacionales] |
publishDate |
2025 |
container_title |
Journal of Pharmacy and Pharmacognosy Research |
container_volume |
13 |
container_issue |
|
doi_str_mv |
10.56499/jppres24.2193_13.s1.13 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-86000282478&doi=10.56499%2fjppres24.2193_13.s1.13&partnerID=40&md5=9e743031b59111df8a093c4782cdd2b1 |
description |
Context: Dracaena trifasciata Prain has shown potential in pharmaceutical research, particularly for its antidiabetic properties. Investigating its effects on α-glucosidase enzyme inhibition can provide insights into its role as an antidiabetic agent. Aims: To evaluate the antidiabetic activity of the ethyl acetate fraction and subfractions from D. trifasciata against α-glucosidase through in vitro assay and analyze molecular interactions, absorption, distribution, metabolism, and excretion (ADME), toxicity, and stability through in silico studies. Methods: An α-glucosidase enzyme assay was performed using the ethyl acetate fraction (FE), subfraction C (SC), and subfraction E (SE) at concentrations of 100, 200, 300, 400, and 500 µg/mL. Acarbose was used as the control. Computational docking, drug-likeness, ADME and toxicity analysis, molecular dynamics, and Molecular Mechanics, General Born Surface Area (MM/GBSA) energy analysis were conducted on methyl pyrophaeophorbide A and (2S)-3',4'-methylenedioxy-5,7-dimethoxyflavone from SE against α-glucosidase. Results: At 500 µg/mL, the inhibition percentages for the FE, SC, SE, and acarbose (1 µg/mL) were 70.11%, 69.89%, 75.17%, and 72.20%, respectively. IC50 values were 170.82 µg/mL (FE), 183.47 µg/mL (SC), 74.89 µg/mL (SE), and 0.29 µg/mL (acarbose). Molecular docking showed (2S)-3',4'-methylenedioxy-5,7-dimethoxyflavone interacting with α-glucosidase via hydrogen bonds with Arg552 and hydrophobic interactions with Asp232, Trp329, Asp469, Asp568, and Phe601. Although the analysis results indicate a safer ADME profile and lower toxicity for methyl pyropheophorbide A compared to (2S)-3',4'-methylenedioxy-5,7-dimethoxyflavone. The (2S)-3',4'-methylenedioxy-5,7-dimethoxyflavone also demonstrated good stability and favorable binding energy (-33.86 kJ/mol) compared to acarbose. © 2025 Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA). All rights reserved. |
publisher |
Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) |
issn |
7194250 |
language |
English |
format |
Article |
accesstype |
|
record_format |
scopus |
collection |
Scopus |
_version_ |
1828987858388516864 |